| 
Citations
 | 
   web
Bruggmann, P. (2009). Alcohol and HCV treatment. In 1st international symposium on hepatitis care in substance users (31). Zurich: Arbeitsgemeinschaft für risikoarmen Umgang mit Drogen (ARUD).
Toggle visibility
Christensen, P. B. (2009). Epidemiology of viral hepatitis among European drug users – a Danes perspective. In 1st International Symposium on Hepatitis care in substance users (49). Zurich: Odense University Hospital, Department of Infectious Diseases.
Toggle visibility
Barrieshee, A., & Conway, B. (2009). HCV infection and re-infection in illicit drug users. In 1st International Symposium on Hepatitis care in substance users (26). Zurich: University of British Columbia, Anesthesiology Pharmacology and Therapeutics.
Toggle visibility
Dore, G. J., Hellard, M., Matthews, G., Grebely, J., Haber, P. S., Petoumenos, K., et al. (2009). Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort : the ATAHC study. In 1st International Symposium on Hepatitis care in substance users (24). Zurich: University of New South Wales (UNSW), National Centre in HIV Epidemiology and Clinical Research; St Vincent's Hospital, HIV/Immunology/Infectious Diseases Clinical Services Unit; Burnet Institute; The Alfred Hospital, Infectious Diseases Unit; Royal Pri.
Toggle visibility
Dore, G. (2009). HCV reinfection among injecting drug users. In 1st International Symposium on Hepatitis care in substance users (40). Zurich: University of New South Wales, National Centre in HIV Epidemiology and Clinical Research, Viral Hepatitis Clinical Research Program.
Toggle visibility
Farley, J. D. (2009). Continuation of treatment of inmates with hepatitis C infection on discharge to the community : the Inmate Community Health Reintegration Services Project (InCoHRS) experience: Vancouver, British Columbia. In 1st International Symposium on Hepatitis care in substance users (47). Zurich.
Toggle visibility
Foster, G. R. (2009). Hepatitis C : what is coming next? In 1st International Symposium on Hepatitis care in substance users (40). Zurich: Barts and The London School of Medicine.
Toggle visibility
Grebely, J., Raffa, J. D., Knight, E., Storms, M., Tossonian, H. K., Duncan, F., et al. (2009). Factors influencing willingness for and uptake of treatment for hepatitis C virus (HCV) infection in illicit drug users in urban care settings in British Columbia, Canada : the HI-Lo Study. In 1st International Symposium on Hepatitis care in substance users (18). Zurich: University of New South Wales (UNSW), National Centre in HIV Epidemiology and Clinical Research; University of Waterloo, Department of Statistics and Actuarial Science; University of British Columbia, Department of Anesthesiology, Pharmacology and Therape.
Toggle visibility
Grebely, J., Matthews, G. V., Petoumenos, K., Pham, S. T., Marks, P., Rawlinson, W., et al. (2009). Hepatitis C virus superinfection and reinfection in injection drug users. In 1st International Symposium on Hepatitis care in substance users (22). Zurich: University of New South Wales (UNSW), National Centre in HIV Epidemiology and Clinical Research; University of New South Wales (UNSW), School of Medical Sciences; Prince of Wales Hospital, SEALS Microbiology, Virology Division; University of Sydney, Centr.
Toggle visibility
Haltmayer, H. (2009). The Vienna hepatitis network, Austria. In 1st International Symposium on Hepatitis care in substance users (16). Zurich: Verein Wiener Sozialprojekte, Ganslwirt; Ärztekammer für Wien; Österreichische Gesellschaft für arzneimittelgestützte Behandlung von Suchtkranken (ÖGABS).
Toggle visibility